Valuation Getinge AB OTC Markets
Stocks
GNGBF
SE0000202624
Medical Equipment, Supplies & Distribution
|
Market Closed -
OTC Markets
12:14:22 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 25.00 USD | +11.16% |
|
-.--% | +13.12% |
| 09-29 | Millennium International Management no longer a public short seller in Getinge | FW |
| 09-28 | SB1 Markets sees underestimated margin potential at Getinge, raises price target | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 67,330 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | 12.98% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 75,571 | 73,341 | 70,858 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | 8.84% | -2.95% | -3.39% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 21.3x | 19x | 16.9x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 2.09x | 1.97x | 1.83x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.5x | 1.6x | 1.3x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.91x | 1.8x | 1.72x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 2.14x | 1.96x | 1.81x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 10.5x | 9.51x | 8.48x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 15x | 13.2x | 11.6x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.2x | 17.7x | 15.4x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.5% | 5.65% | 6.51% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.186 | 5.652 | 6.044 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.1% | 2.29% | 2.44% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 11.59 | 12.98 | 14.65 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 44.8% | 43.5% | 41.3% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,284 | 37,327 | 39,154 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 7,172 | 7,711 | 8,354 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 5,042 | 5,544 | 6,086 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 3,172 | 3,560 | 3,999 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,241 | 6,011 | 3,528 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 247.20 | 247.20 | 247.20 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 1/28/22 | 2/1/23 | 2/1/24 | 1/28/25 | 1/27/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28x | 3.88x | 15.01x | 2.6% | 171B | |
| 18.25x | 3.37x | 12.03x | 3.26% | 110B | |
| 21.42x | 4.21x | 14.72x | 1.31% | 106B | |
| 25.75x | 2.52x | 10.21x | 2.8% | 75.99B | |
| 16.44x | 0.19x | 12.1x | 0.79% | 57.3B | |
| 34.49x | 3.36x | 11.49x | 2.19% | 48.76B | |
| 28.75x | 7.1x | 18.34x | 1.39% | 50.19B | |
| 35.36x | 8.79x | 24.72x | -.--% | 41.14B | |
| 34.67x | 6.08x | 19.09x | -.--% | 32.56B | |
| Average | 27.02x | 4.39x | 15.30x | 1.59% | 77B | |
| Weighted average by Cap. | 25.50x | 3.99x | 14.49x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- GNGBF Stock
- Valuation Getinge AB
Select your edition
All financial news and data tailored to specific country editions
